TY - JOUR
T1 - Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage
T2 - A single-blind phase III multicentre randomized controlled trial (FLUOCOL-01/FRENCH 21/GRECCAR 19 intergroup trial)
AU - FLUOCOL Study Group
AU - Pretalli, Jean Baptiste
AU - Vernerey, Dewi
AU - Evrard, Philippe
AU - Pozet, Astrid
AU - Clairet, Anne Laure
AU - Benoist, Stéphane
AU - Karoui, Mehdi
AU - Cotte, Eddy
AU - Heyd, Bruno
AU - Lakkis, Zaher
AU - Regimbeau, Jean Marc
AU - Dabrowski, Antoine
AU - Goubault, Pierre
AU - Moreno-Lopez, Nathan
AU - Trilling, Bertrand
AU - Piessen, Guillaume
AU - Jafari, Mehrdad
AU - Gignoux, Benoit
AU - Mege, Diane
AU - Beyer-Berjot, Laura
AU - Fara, Régis
AU - De Chaisemartin, Cécile
AU - Leconte, Mahaut
AU - Lefevre, Jérémie
AU - Maggiori, Léon
AU - Loriau, Jérôme
AU - Trelles, Nelson
AU - Perrenot, Cyril
AU - Tuech, Jean Jacques
AU - Sina, Antoine
AU - Romain, Benoit
AU - Ouaissi, Mehdi
AU - Benhaim, Léonor
AU - Oulie, Olivier
AU - Orry, David
AU - Manceau, Gilles
AU - Buscail, Etienne
AU - Desfourneaux-Denis, Véronique
AU - Denost, Quentin
AU - Ceribelli, Cécilia
AU - Rossi, Caroline
N1 - Publisher Copyright:
© 2025 The Author(s). Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.
PY - 2025/5/1
Y1 - 2025/5/1
N2 - Aim: Anastomotic leak (AL) is a major problem in colorectal surgery, and its prevention is crucial for patient safety. The scientific literature shows that optimal anastomotic perfusion is essential for anastomotic healing. However, in cases of left colon or rectal cancer requiring high vessel ligation for oncological reasons, anastomotic blood supply relies mainly on the pericolic arterial arcades. Consequently, assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green might be relevant to reduce the risk of AL. Although evidence of its positive impact on the risk of AL is growing in the literature, most studies are descriptive prospective cohorts or retrospective comparative series with controversial findings. Furthermore, no other studies specifically address left-sided colon or high rectal tumours. FLUOCOL-1 is a large multicentre randomized controlled trial (RCT) that aims to demonstrate that assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in left-sided or high anterior resections with intraperitoneal anastomosis. Method: FLUOCOL-1 is a French multicentre, single-blind, randomized, two-arm, phase III superiority clinical trial. Patients will be randomized in a 1:1 ratio to either the intervention group (FLUO+) or the control group (FLUO−). A total of 1010 patients will be randomized. The primary endpoint is the occurrence of an AL within 90 days postsurgery. AL is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed by imaging or surgical exploration, or any isolated pelvic organ-space infection with no evidence of fistula, as defined by the International Study Group of Rectal Cancer. Discussion: Prevention of AL is one of the most important questions to be addressed in colorectal surgery. The FLUOCOL-1 multicentre RCT described herein aims to demonstrate that assessment of anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in certain resections with intraperitoneal anastomosis.
AB - Aim: Anastomotic leak (AL) is a major problem in colorectal surgery, and its prevention is crucial for patient safety. The scientific literature shows that optimal anastomotic perfusion is essential for anastomotic healing. However, in cases of left colon or rectal cancer requiring high vessel ligation for oncological reasons, anastomotic blood supply relies mainly on the pericolic arterial arcades. Consequently, assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green might be relevant to reduce the risk of AL. Although evidence of its positive impact on the risk of AL is growing in the literature, most studies are descriptive prospective cohorts or retrospective comparative series with controversial findings. Furthermore, no other studies specifically address left-sided colon or high rectal tumours. FLUOCOL-1 is a large multicentre randomized controlled trial (RCT) that aims to demonstrate that assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in left-sided or high anterior resections with intraperitoneal anastomosis. Method: FLUOCOL-1 is a French multicentre, single-blind, randomized, two-arm, phase III superiority clinical trial. Patients will be randomized in a 1:1 ratio to either the intervention group (FLUO+) or the control group (FLUO−). A total of 1010 patients will be randomized. The primary endpoint is the occurrence of an AL within 90 days postsurgery. AL is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed by imaging or surgical exploration, or any isolated pelvic organ-space infection with no evidence of fistula, as defined by the International Study Group of Rectal Cancer. Discussion: Prevention of AL is one of the most important questions to be addressed in colorectal surgery. The FLUOCOL-1 multicentre RCT described herein aims to demonstrate that assessment of anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in certain resections with intraperitoneal anastomosis.
KW - anastomotic leakage
KW - colic surgery
KW - colorectal surgery
KW - complication
KW - fluorescence angiography
KW - indocyanine green
KW - prevention
UR - http://www.scopus.com/inward/record.url?scp=105007105966&partnerID=8YFLogxK
U2 - 10.1111/codi.70119
DO - 10.1111/codi.70119
M3 - Article
AN - SCOPUS:105007105966
SN - 1462-8910
VL - 27
JO - Colorectal Disease
JF - Colorectal Disease
IS - 5
M1 - e70119
ER -